MIFLONID 200
200MCG INH PLV CPS DUR 120
| SÚKL code | 0016304 |
|---|---|
| Name of the product | MIFLONID 200 |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | MIFLONID 200 |
| Supplement | 200MCG INH PLV CPS DUR 120 |
| Strenght | 200MCG |
| Pharmaceutical form | Inhalation powder, hard capsule |
| Package | 120 |
| Route | Inhalation use |
| Language of the pack | Czech |
| Wrap type | Tablet container |
| Legal status | na lékařský předpis |
| Active substance | BUDESONIDE (BUDESONIDUM) |
| ATC group | R03BA02 |
| ATC group name | BUDESONID |
Marketing authorisation information
| Registration Number | 14/ 232/00-C |
|---|---|
| Type of MA | National |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 03. 2017 |
| MA Holder | Novartis s.r.o., Praha |
| MA Holder country | ČESKÁ REPUBLIKA |
| Actual MA holder | Novartis s.r.o., Praha |
| Actual MA holder country | ČESKÁ REPUBLIKA |
cz